Skip to main content

Table 2 Baseline characteristics of the study groups

From: Circulating adiponectin levels, expression of adiponectin receptors, and methylation of adiponectin gene promoter in relation to Alzheimer’s disease

 

AD (n = 98)

Control (n = 150)

p value

Age (years)

68 (63–74)

67 (61–74)

0.412

Gender, n (%)

Male

Female

29 (29.6%)

69 (70.4%)

58 (38.7%)

92 (61.3%)

0.143

Ethnicity, n (%)

Kazakh

Russian

Other

72 (74.2%)

15 (15.5%)

10 (10.3%)

117 (78%)

24 (16%)

9 (6%)

0.475

Apo e4 carrier, n (%)

46 (46.9%)

36 (24%)

0.002

BMI, kg/m2

23.5 (21.9–26.7)

27.4 (24.8–29.8)

< 0.001

MMSE score

14.5 (6–21)

29 (28–30)

< 0.001

Total cholesterol, mmol/L

4.73 (3.79–5.5)

4.63 (3.97–5.36)

0.948

HDL-C, mmol/L

1.2 (0.96–1.5)

1.27 (1.01–1.49)

0.553

LDL-C, mmol/L

3.22 (2.53–3.94)

2.83 (2.4–3.61)

0.059

Triglycerides, mmol/L

1.07 (0.79–1.42)

1.34 (0.91–1.92)

0.003

Fasting glucose

4.96 (4.35–5.72)

4.45 (3.94–5.18)

0.007

Adiponectin (μg/ml)

19.1 (9.9–30.7)

6.2 (2.9–12.7)

< 0.001

  1. The data is presented in medians (IQR) for continuous and as n (%) for categorical variables